Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status - Wikidata - awgldk - TriplyDB

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

http://www.wikidata.org/entity/Q37003753

about

Patient-centered care for people living with multimorbidity Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART Antiretroviral therapy: Shifting sands Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?When to start antiretroviral therapy: the need for an evidence base during early HIV infection Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.Antiretroviral Therapy (ART) Use, Human Immunodeficiency Virus (HIV)-1 RNA Suppression, and Medical Causes of Hospitalization Among HIV-Infected Intravenous Drug Users in the Late ART Era.Psychosocial factors as predictors of HIV/AIDS risky behaviors among people living with HIV/AIDS.Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes Haemoglobin and anaemia in the SMART study.Immunodiscordant responses to HAART--mechanisms and consequences.Policy modeling to support administrative decisionmaking on the New York state HIV testing law.Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.Examining the relationship between multiple comorbidities and retention in HIV medical care: a retrospective analysis.Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

P2860

Q27000743-3A5555D2-DA6A-4CB2-8961-2D050284D2E9 Q28539369-460C44E1-96E5-4D7C-9520-9E80F621F24C Q28542548-65011A2A-F25E-40BC-AE25-0EC5B98386A2 Q30384683-69C0BC52-D9F0-4287-8E92-A31B1E1C6E26 Q33897770-C6CABAF6-D103-4292-B7EA-D3D41E0D5DA6 Q33963850-E330FEDF-3E90-4886-8DB0-30D01C7E474D Q34027867-70784C5A-95B3-4CCA-81B7-C21742422485 Q34773308-7FE697A6-BA70-4118-B636-AE56F96C5BE6 Q35030752-B113C891-ED8F-4763-823A-607A568BE76A Q35072003-8D5CFBC5-A54A-40E8-96DF-B0A3A8B81DE7 Q35777845-44705BED-0C33-4A02-95A7-AD88B503B2A6 Q36661756-43291B6C-CE4D-42F6-BBE5-9BE4A2F0B47C Q36671999-23209765-BD2B-49C7-87BB-6F71148FC45C Q37244544-D09F9863-417B-41CE-9274-F5F803657EFC Q37541128-ED659FAD-CCDB-464C-B851-2AC06B9590F5 Q38156230-36AB2423-323E-4850-94DA-A461175D5EF2 Q39016196-6D087327-DF67-4455-B579-9BCC48422A30 Q40196920-89B80375-F514-4BF5-B59F-627034CAC36F Q41439720-6FC25307-DAC3-4BB0-A22B-36264250411E Q42202541-994AB797-9D7F-4F0E-906A-6AE6E66A8AC9 Q47655423-C9DCB4BE-8759-4DD5-A6B9-DB018AF6B8D3

P2860

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status

http://www.wikidata.org/entity/Q37003753

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rate of comorbidities not rela ...... ell count and HAART use status

@en

Rate of comorbidities not rela ...... ll count and HAART use status.

@nl

type

label

Rate of comorbidities not rela ...... ell count and HAART use status

@en

Rate of comorbidities not rela ...... ll count and HAART use status.

@nl

prefLabel

Rate of comorbidities not rela ...... ell count and HAART use status

@en

Rate of comorbidities not rela ...... ll count and HAART use status.

@nl

P1433

Q37003753-27B12837-34BE-4124-901E-F8A1A3377B74

P1476

Q37003753-08543FDD-7768-464A-85D5-934490763B50

P2093

Q37003753-362F2B68-A539-4C18-B489-4D64B6D046E8

Q37003753-533AC501-FF59-4061-9B18-1A8115769897

Q37003753-B9497F6E-CCDB-486E-83CC-087371A1B451

Q37003753-D04DAC98-B3B9-4A95-B5AE-B9A1A6373DEA

P2860

Q37003753-1B1E2D79-5C48-4B2C-B47E-7D1ACD7495E7

Q37003753-44451A24-301F-4E9D-BA4C-569E74C44526

Q37003753-475775E5-DD92-4AC0-9C18-10B4C5733564

Q37003753-55A27765-5DFF-478D-A1D7-541C600F9A2B

Q37003753-88D33CDA-4494-4BA5-A353-5F99B99B73D8

Q37003753-A85B70C4-BE0D-4DF2-BBD3-AF7BDA3E08D4

Q37003753-B08E8E54-D41C-43AC-BE18-BD63742AD750

Q37003753-B4ACB971-2E93-4FDE-A7F0-260704713A62

Q37003753-DF866597-3CAF-4D83-8DF5-9812B0FB73F7

Q37003753-E50B17F5-02F7-47C7-94DE-7162A215E849

P304

Q37003753-CB355937-F659-4A6B-A541-CEA18FE1BE59

P31

Q37003753-6733C036-75B9-4E69-A849-2751A8857079

P356

Q37003753-41CE8F07-664D-4733-8966-9A82F08CD108

P407

Q37003753-E74AC814-BAB1-4710-9172-9EA4B67B8EC9

P433

Q37003753-BCE5EAD2-BC2B-43C7-BA3C-99574FD7E198

P478

Q37003753-2985317D-27AA-46A7-BE8B-0061934DB10F

P577

Q37003753-A496B51D-F9C2-4E92-A4D4-7E2D2C6C72D5

P5875

Q37003753-456C64D0-E857-48B1-8CEF-98C94C95B8DC

P698

Q37003753-B73D1355-23A2-4CAB-B846-B7C4779C49FF

P921

Q37003753-2966AF39-E18C-4F4A-9EEF-AA46966684FE

Q37003753-807FFC73-49C1-4D44-AA16-7DAC827949F8

P932

Q37003753-3C7109E7-0531-46E6-8F85-B3B6FC8A5809

P356

P1433

Clinical Infectious Diseases

P1476

Rate of comorbidities not rela ...... ell count and HAART use status

@en

P2093

Gregory M Lucas

http://www.w3.org/2001/XMLSchema#string

Jeanne C Keruly

http://www.w3.org/2001/XMLSchema#string

Kelly A Gebo

http://www.w3.org/2001/XMLSchema#string

Richard D Moore

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ count-guided interruption of antiretroviral treatment

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Racial and ethnic disparities in the VA health care system: a systematic review.

U.S. disparities in health: descriptions, causes, and mechanisms.

Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

Estimating the proportion of patients infected with HIV who will die of comorbid diseases.

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.

Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

P304

1102-1104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/592115

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23247617

http://www.w3.org/2001/XMLSchema#string

P698

18781885

http://www.w3.org/2001/XMLSchema#string

P921

P932

2597666

http://www.w3.org/2001/XMLSchema#string